| Stats | Twitter歴 3,533日（2009/04/14より） |
ツイート数 68,523（19.3件/日） |
表示するツイート :
Naoto Ueno, MD, PhD@teamoncology
Career Development Program for Team Members in the field of Oncology (CAP-J) starts. A good multidiscilinary cancer team originates from a strong individual career plan. https://pic.twitter.com/5uJwM72Gsa
posted at 14:37:58
Naoto Ueno, MD, PhD@teamoncology
My lunch, Yamayuri. 明治座 やまゆり。 https://pic.twitter.com/Fu4rOZKymW
posted at 11:21:41
Naoto Ueno, MD, PhD@teamoncology
@DadPerfume @Perfume_Staff @amuse_official Thanks
posted at 11:16:23
Naoto Ueno, MD, PhD@teamoncology
@r_snr2 @Perfume_Staff @amuse_official Amuseを説得できると良いんですがね。頑張ります。
posted at 11:15:57
Naoto Ueno, MD, PhD@teamoncology
Tasting the World’s First Test-Tube Steak. Meat from the test tube. The chicken nugget is almost ready for commercialization. https://youtu.be/bjSe-0vSRMY
posted at 08:07:38
Naoto Ueno, MD, PhD@teamoncology
【2018 Social Media Trend for Medicine】 Capitalism at max when people need to request donations so that they can continue their medical treatment. I noticed that there are more of these posting by social media in 2018. Is this a sign of financial toxicity grade is going up?
posted at 03:22:28
Naoto Ueno, MD, PhD@teamoncology
Not just stem cell transplantation docs but any cancer doctors. I do not agree with the word ”palliative.” I prefer ”Supportive Care” or ”Symptom Management” clinic. https://twitter.com/yzafar/status/1073319901664825346…
posted at 03:21:16
Naoto Ueno, MD, PhD@teamoncology
あ〜ちゃんファン13年。横浜アリーナであ〜ちゃんにいじっていただき幸せでした。@Perfume_Staff Dream Fighterがガン撲滅キャンペーンに使用できないか日野原重明先生と @amuse_officialにお願いし断られた経緯があります。来年の夢はDFがガン撲滅キャンペーンに使用許可取得を頑張ります。#prfm https://twitter.com/1998serena/status/1073412628272209925…
posted at 13:19:12
Naoto Ueno, MD, PhD@teamoncology
My week on Twitter 🎉: 40 Mentions, 38.8K Mention Reach, 405 Likes, 162 Retweets, 583K Retweet Reach. See yours with https://sumall.com/performancetweet?utm_source=twitter&utm_medium=publishing&utm_campaign=performance_tweet&utm_content=text_and_media&utm_term=f68614ae1b9f4c54edcfbdb9… https://pic.twitter.com/0bl9TVBZZy
posted at 11:00:34
Naoto Ueno, MD, PhD@teamoncology
Our biggest fans this week: @medpagetoday, @itoshunya, @MaverickNY. Thank you! via https://sumall.com/thankyou?utm_source=twitter&utm_medium=publishing&utm_campaign=thank_you_tweet&utm_content=text_and_media&utm_term=f68614ae1b9f4c54edcfbdb9… https://pic.twitter.com/UnHTxZimI5
posted at 00:01:38
Naoto Ueno, MD, PhD@teamoncology
@Perfume_Oji こちらこそ宜しくお願い致します🤲
posted at 11:02:08
Naoto Ueno, MD, PhD@teamoncology
@Tsumugu41 宜しくお願い致します🤲
posted at 10:42:52
Naoto Ueno, MD, PhD@teamoncology
@mieMD ありがとうございます。
posted at 10:27:22
Naoto Ueno, MD, PhD@teamoncology
@mieMD Yep! It is me! LOL
posted at 10:26:42
Naoto Ueno, MD, PhD@teamoncology
@Perfume_Oji 正確にはヒューストンです。ダラスの隣町です。
posted at 10:06:48
Naoto Ueno, MD, PhD@teamoncology
@itoshunya 確かに。PerfumeのDream Fighterという曲をがんテーマ曲にしたいんです。
posted at 10:05:17
Naoto Ueno, MD, PhD@teamoncology
@shironta That is so true. Next time.
posted at 08:56:45
Naoto Ueno, MD, PhD@teamoncology
@Perfume_Oji Thank you!!
posted at 08:55:58
Naoto Ueno, MD, PhD@teamoncology
@PTA0531_Prfm ありがとございます
posted at 07:40:36
Naoto Ueno, MD, PhD@teamoncology
@Haruna1029 @Perfume_Staff うれしかったです。
posted at 06:51:34
Naoto Ueno, MD, PhD@teamoncology
@sgruuu_62P @arsperfume 感無量です。
posted at 06:49:54
Naoto Ueno, MD, PhD@teamoncology
@aikodrum @tabbata ありがとうございます。頭はよくないですけど。
posted at 06:49:40
Naoto Ueno, MD, PhD@teamoncology
@kojihanko 感謝です。
posted at 06:49:19
Naoto Ueno, MD, PhD@teamoncology
@Perfume_Oji ありがとうございます。
posted at 06:49:04
Naoto Ueno, MD, PhD@teamoncology
@toomomighty ありがとうございます。ダラスも盛り上がります。
posted at 06:48:54
Naoto Ueno, MD, PhD@teamoncology
@crf5143 了解です。
posted at 23:04:42
Naoto Ueno, MD, PhD@teamoncology
僕は幹細胞移植中、Perfumeのポスターを無菌室の壁に消毒して貼っていた。本当はPerfumeのあ〜ちゃんがどれだけこころの支えになって。今、元気に横浜アリーナでライブ参戦出来たことを伝えたかった。@Perfume_Staff #prfm
posted at 22:54:18
Naoto Ueno, MD, PhD@teamoncology
@p_discogirl ダラスでもあーちゃんに声をかけます
posted at 22:46:09
Naoto Ueno, MD, PhD@teamoncology
@Perfume_TikTok @moreperfumefan ありがとうございます
posted at 22:45:51
Naoto Ueno, MD, PhD@teamoncology
@outcosmo 涙が出るほど嬉しかったです。一緒に喜んでありがとうございます。感無量です。
posted at 22:43:59
Naoto Ueno, MD, PhD@teamoncology
Perfume あ〜ちゃんと会話。
医師の人と言われてて当てられた。あ〜ちゃんは何科と聞いていたのだが、思わずテキサスから来て今度ダラスのコンサートに行くと答え。その後、乳がんと応えた。そしたらお世話になるかもしないねでもそれよりも検診受けることが大切ねと言った。最高の思い出。 #prfm
posted at 22:28:58
Naoto Ueno, MD, PhD@teamoncology
A peaceful moment. https://pic.twitter.com/T5wMUJaCyy
posted at 10:27:51
Naoto Ueno, MD, PhD@teamoncology
RIP Dr. Charles A. Coltman a co-founder of the San Antonio Breast Cancer Symposium @SABCSSanAntonio and long-time co-chair of @SWOG passed away on 11/28. We will miss him very much. Thank you for your service. https://cancerletter.com/articles/20181207_4/…
posted at 04:46:03
Naoto Ueno, MD, PhD@teamoncology
【Take Home Message from #SABCS18 】 Oxybutynin is effective to control hot flashes. An additional choice for those who are suffering from a hot flash. #bcsm
posted at 23:42:57
Naoto Ueno, MD, PhD@teamoncology
【Take Home Message from #SABCS18 】 Positive study for KATHERINE study. If you have residual disease after receiving preoperative systemic therapy, adjuvant T-DM1 is better than adjuvant trastuzumab (Herceptin). An impressive outcome.
posted at 23:42:07
Naoto Ueno, MD, PhD@teamoncology
【Take Home Message from #SABCS18 】Two studies have shown that exercise may help to improve the cardiovascular function and may even impact the outcome (disease recurrence and survival) of breast cancer. Not definitive studies but very suggestive.
posted at 23:41:40
Naoto Ueno, MD, PhD@teamoncology
@united Terminal E @iah has a very poor access for the GS, preTSA, POORLY MANAGED CHECK IN and @TSA access. We should abolish the differential access if you are going to screen everybody and not plan to staff enough at a busy time.
posted at 23:11:16
Naoto Ueno, MD, PhD@teamoncology
【Take Home Message #SABCS18】 Impassion130 showed that PDL1 inhibitor is beneficial when combined with chemo. The benefit was stronger with PDL1 positivity. There was no benefit in PDL1 negative study. And the threshold positivity is 1%. The test is not standardized yet.
posted at 22:51:29
Naoto Ueno, MD, PhD@teamoncology
@dani_carey_ Intensive excericise may suggest to live longer and less recurrence. The main study outcome was negative but a very interesting secondary outcome. Not defensive but very likely.
posted at 22:44:16
Naoto Ueno, MD, PhD@teamoncology
前半30分出演し患者力の話をしました。見て下さい。拡散お願い。患者力をつけるポイントがわかると、受けている医療の質がよくなり、納得のできる医療を受けられます。名医探しも必要なしです。「一流患者と三流患者」（朝日新書）に患者力のポイントをまとめています。よろしくお願い致します。 https://twitter.com/nhk_ondemand/status/1071638080484831233…
posted at 20:38:33
Naoto Ueno, MD, PhD@teamoncology
What These Medical Journals Don’t Reveal: Top Doctors’ Ties to Industry. Need to read, some of you know these docs. We all need to make every effort to disclose COI. Also, we need to show our tweet can have COI by adding #COI and compnay name. https://nyti.ms/2G8UXvq
posted at 23:33:54
Naoto Ueno, MD, PhD@teamoncology
@DrHBurstein We need to also disclose COI even in our tweets. Clearly, we see bias when you are paid and providing an opinion at the social media.
posted at 23:32:28
Naoto Ueno, MD, PhD@teamoncology
【一流患者と三流患者 医者から最高の医療を引き出す心得 (朝日新書）】NHKで紹介していただきアマゾンで科学’医学でランキング一位です。NHKの力は絶大です。印税はすべて寄付しました、今後も寄付予定です。是非、患者力を高め頂き、寄付を増やしたいです。拡散お願い。https://www.amazon.co.jp/dp/4022736623/ref=cm_sw_r_tw_dp_U_x_BdrdCbP4BF0SQ…
posted at 22:09:43
Naoto Ueno, MD, PhD@teamoncology
My book about how to receive the best cancer care as a patient has ranked number three in the science related in Amazon Japan. https://twitter.com/a_ranking_news/status/1071449595018768389…
posted at 02:38:19
Naoto Ueno, MD, PhD@teamoncology
It was a fun mtg. Going home to Houston. See you next year. Safe travel home. @SABCSSanAntonio @AACR #SABCS18
posted at 00:39:38
Naoto Ueno, MD, PhD@teamoncology
Outcome after a long visit. Tomorrow’s the last day. #SABCS18 https://pic.twitter.com/xk4J093sd3
posted at 09:54:33
Naoto Ueno, MD, PhD@teamoncology
Myc pathways be the reason why ER+ inflammatory breast cancer is aggressive. #SABCS18 https://pic.twitter.com/3Dok8A5Ani
posted at 09:38:07
Naoto Ueno, MD, PhD@teamoncology
We developed the first humanized inflammatory breast cancer mouse model. #SABCS18 https://pic.twitter.com/FL2PyFvkux
posted at 09:31:29
Naoto Ueno, MD, PhD@teamoncology
The best poster position to increase the traffic of our poster. LOL #SABCS18 https://pic.twitter.com/8puodXMo0i
posted at 09:29:44
Naoto Ueno, MD, PhD@teamoncology
#SABCS18 Summary
1 Ad T-DM1 in the residual Dz
2 Oxybutinin for hot flash
3 De-escalation of TAM for Non-invasive cancer
4 May need adjuvant AI for 10 y
5 HER3-ADC is effective.
6 ICI did not improve T-DM1
7 No Adj Xeloda for low risk TNBC
8 Intensive exercise may impact outcome
posted at 04:15:27
Naoto Ueno, MD, PhD@teamoncology
Using for oxybutynin for hot flash, we should not use the oxybutynin with patients who have urinary retentions issue, cognitive function or history of problems with other anticholinergic drugs. Also, it may be an issue with the elderly. #SABCS18
posted at 04:06:02
